Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03078400
Title Safety and Efficacy Study of Daily SPL-108 Injections In Conjunction With Paclitaxel in Women With Ovarian Cancer
Recruitment Unknown status
Gender female
Phase Phase I
Variant Requirements No
Sponsors Splash Pharmaceuticals, Inc.
Indications

ovary epithelial cancer

Therapies

SPL-108

Age Groups: adult
Covered Countries USA


No variant requirements are available.